摘要:
Compounds are described that are active on at least one of PPARα, PPARδ, and PPARϜ, which are useful for therapeutic and/or prophylactic methods involving modulation of at least one of PPARα, PPARδ, and PPARϜ.
摘要:
Compounds are described that are active on PPARs, including pan-active compounds and compounds selective for any one or any two of PPARα, PPARϜ and PPARδ. Also describe are methods of use of the compounds in treating various diseases.
摘要:
Compounds are described that are active on at least one of PPARα, PPARδ, and PPARϜ, which are useful for therapeutic and /or prophylactic methods involving modulation of at least one of PPARα, PPARδ, and PPARϜ.
摘要:
Compounds are described that are active on PDE4. Also described are crystal structures of PDE4B determined using X-ray crystallography, the use of PDE4B crystals and stractural information for identifying molecular scaffolds, for developing ligands that bind to and modulate PDE4B, and for identifying improved ligands based on known ligands.
摘要:
Compounds as shown below are described that are active on at least one of PPARα, PPARδ, and PPARγ, which are useful for therapeutic and/or prophylactic methods involving modulation of at least one of PPARα, PPARδ, and PPARγ.
摘要:
Compounds are described that are active on at least one of PPARα, PPARδ, and PPARϜ, which are useful for therapeutic and/or prophylactic methods involving modulation of at least one of PPARα, PPARδ, and PPARϜ . wherein R1 is selected from the group consisting of -C(O)OR18R19, and a carboxylic acid isostere.